SuperGen President & CEO Elected to BIO Board of Directors DUBLIN, Calif., Jun 28, 2011 (BUSINESS WIRE) -SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer t

Source URL: astx.com

Astex Pharmaceuticals Announces March 27th Analyst and Investor Day Agenda DUBLIN, Calif.--(BUSINESS WIRE)-- Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to the discovery and development

Source URL: astx.com

Evidence of AT13387 Activity in Gastrointestinal Stromal Tumor Models Presented at ECCO DUBLIN, Calif.--(BUSINESS WIRE)-- Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), a pharmaceutical company dedicated to the discovery an

Source URL: astx.com

• Indoles
• Organofluorides
• Pfizer
• Pyrroles
• Sunitinib
• Lactams
• Gastrointestinal stromal tumor
• Hsp90
• Imatinib
• Chemistry
• Organic chemistry
• Medicine

September 21, 2012 Astex Pharmaceuticals Discontinues Amuvatinib Clinical Development Program DUBLIN, Calif., Sept. 21, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedica

Source URL: astx.com

• Organic chemistry
• Alkynes
• Astex
• Small-cell carcinoma
• Clinical trial
• Homologous recombination
• Erlotinib
• Medicine
• Chemistry
• Lung cancer

January 16, 2013 Cancer Research UK and Cancer Research Technology Initiate AT13148 Clinical Trial to Treat Several Cancer Types DUBLIN, Calif., Jan. 16, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX

Source URL: astx.com

• Cancer organizations
• Cancer research
• Association of Commonwealth Universities
• Institute of Cancer Research
• University of London
• Astex
• Cancer Research UK
• Abiraterone
• Medical research
• Medicine
• Health
• Oncology

October 24, 2012 Astex Pharmaceuticals Announces Initiation of AT13387 Phase 2 Study in Non-Small Cell Lung Cancer DUBLIN, Calif., Oct. 24, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceu

Source URL: astx.com

• Organofluorides
• Piperidines
• Lung cancer
• Crizotinib
• Pyrazoles
• Anaplastic lymphoma kinase
• Non-small-cell lung carcinoma
• Hsp90
• Erlotinib
• Chemistry
• Organic chemistry
• Pfizer

June 13, 2012 Astex Pharmaceuticals Earns $5.4 Million Milestone on Phase I Trial Initiation of a FGFR Kinase Inhibitor DUBLIN, Calif., June 13, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a phar

Source URL: astx.com

• Protein kinase inhibitor
• Drug discovery
• Pharmaceutical sciences
• Pharmacology
• Astex

Astex Pharmaceuticals to Host Annual Analyst and Investor Day on March 27, 2012 DUBLIN, Calif.--(BUSINESS WIRE)-- Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to the discovery and develop

Source URL: astx.com

Astex Pharmaceuticals to Present AT26893, a Novel Targeted Approach to the Treatment of HCV at EASL DUBLIN, Calif., April 13, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX - News), a pharmaceutical co

Source URL: astx.com

• Antiviral drug
• Allosteric regulation
• Astex
• Hepatitis C virus
• Proteins

July 10, 2012 Astex Board Member Wins 2012 European Mediscience Award DUBLIN, Calif., July 10, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and

Source URL: astx.com

• Astex
• Evotec
• Vernalis plc